Identification of multicohort-based predictive signature for NMIBC recurrence reveals SDCBP as a novel oncogene in bladder cancer
Background Despite surgical and intravesical chemotherapy interventions, non-muscle invasive bladder cancer (NMIBC) poses a high risk of recurrence, which significantly impacts patient survival. Traditional clinical characteristics alone are inadequate for accurately assessing the risk of NMIBC recu...
Saved in:
Main Authors: | Chen Zhang, Hubin Yin, Tinghao Li, Junrui Chen, Weiyang He, Ke Ren, Bo Li, Xudong Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2025-12-01
|
Series: | Annals of Medicine |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/07853890.2025.2458211 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Epithelial cell diversity and immune remodeling in bladder cancer progression: insights from single-cell transcriptomics
by: Jianpeng Li, et al.
Published: (2025-01-01) -
On the invariance of the digital description of a handwritten signature
by: U. Yu. Akhundjanov, et al.
Published: (2023-02-01) -
A Multi-Signature Scheme for Defending Malleability Attack on DeFi
by: Chen Zhang, et al.
Published: (2025-01-01) -
Sex-specific differences in recurrence and progression following cytostatic intravesical chemotherapy for non-muscle invasive urothelial bladder cancer (NMIBC)
by: Laila Schneidewind, et al.
Published: (2025-02-01) -
Homomorphic Signature With Designated Evaluator
by: Kazuma Shiraishi, et al.
Published: (2025-01-01)